- Physician's Weekly

How Physicians Can Engage in Social Media Use Without Inviting a Malpractice Suit

Nov 7, 2023

Maintaining the utmost professionalism on social media apps is essential for physicians.

Bearing Witness to Life’s Milestones

Nov 6, 2023

As we move through our lives and progress through their various stages, we sometimes forget what got us to where we were going.

Does Lesion Location in Geographic Atrophy Impact Quality of Life?

Nov 6, 2023

A recent study tries to paint a clearer picture of the correlation between structural and functional markers of geographic atrophy.

Lifestyle Intervention Linked With Higher pCR in Women on Neoadjuvant Chemo

Nov 3, 2023

Patients in the intervention group significantly improved their diet quality and physical activity levels from baseline, compared with those in usual care.

FOLFIRINOX Equals Gemcitabine-Based Chemoradiotherapy for Pancreatic Cancer

Nov 2, 2023

Neoadjuvant FOLFIRINOX and gemcitabine-based chemoradiotherapy were comparably effective for pancreatic cancer.

Erdafitinib Similar to Pembrolizumab for Urothelial Cancer

Nov 2, 2023

Erdafitinib did not outperform pembrolizumab as second-line treatment for metastatic urothelial carcinoma.

Short Induction Chemo Improves Survival in Advanced Cervical Cancer

Nov 2, 2023

Carboplatin/paclitaxel induction chemotherapy, directly followed by standard chemoradiotherapy, improved survival in locally advanced cervical cancer.

First Effective First-Line Chemo/Immunotherapy Combo for Urothelial Cancer

Nov 2, 2023

Nivolumab plus chemotherapy is the first combination to outperform chemotherapy alone as first-line treatment for unresectable or metastatic urothelial cancer.

Superior PFS With Sotorasib in Colorectal Cancer

Nov 2, 2023

Patients with KRAS (G12C)-mutated, metastatic colorectal cancer (CRC) benefit from combination sotorasib and panitumumab

“LAG Time” Promising First-Line Treatment for Metastatic NSCLC

Nov 2, 2023

Soluble LAG-3 protein eftilagimod alpha combined with pembrolizumab shows promising clinical efficacy as first-line treatment for advanced or metastatic NSCLC.

How Fair Is the Standard of Care?

Nov 2, 2023

If every patient is unique, can an overarching metric really be pinned down enough to declare that a given doctor was negligent as a legal certainty?

Innovative & Insightful IBS-C Peer to Peer eBook

Nov 1, 2023

An innovative, curated ebook featuring insightful IBS-C findings and input from key opinion leaders in the field of gastroenterology.

Q&A: Collaboration Improves PrEP Uptake in Latino MSM

Nov 1, 2023

Collaboration among healthcare providers and community-based organizations may be a viable strategy to increase PrEP uptake among Latino MSM.

Vitals

Nov 1, 2023

“I’m here to check your vitals – Instagram, Twitter and Facebook pages.”

Q&A: Availability of Multiple Options for NSCLC is “Very Exciting”

Oct 31, 2023

Selecting a treatment for operable non-small cell lung cancer from the many options available involves consideration of tumor stage and biomarkers.

Primary Care Intervention Aids Patient Follow-Up for Abnormal Cancer Screening

Oct 31, 2023

Primary care clinicians take a “whole person” approach and are responsible for a wide range of preventive healthcare efforts.

Healthcare Organizations Can Do More for Women Leaders in Academic Medicine

Oct 31, 2023

Women are underrepresented in leadership positions in a wide range of industries, and medicine is no exception. Healthcare organizations can do more for women.